Zevalin

Product manufactured by Acrotech Biopharma Llc

Application Nr Approved Date Route Status External Links
BLA125019 None None None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Zevalin Is A Cd20-Directed Radiotherapeutic Antibody Administered As Part Of The Zevalin Therapeutic Regimen Indicated For The Treatment Of Adult Patients With: • Relapsed Or Refractory, Low-Grade Or Follicular B-Cell Non-Hodgkin's Lymphoma (Nhl) ( 1.1 ). • Previously Untreated Follicular Nhl Who Achieve A Partial Or Complete Response To First-Line Chemotherapy ( 1.2 ). 1.1 Relapsed Or Refractory, Low-Grade Or Follicular Nhl Zevalin Is Indicated For The Treatment Of Adult Patients With Relapsed Or Refractory, Low-Grade Or Follicular B-Cell Non-Hodgkin's Lymphoma (Nhl). 1.2 Previously Untreated Follicular Nhl Zevalin Is Indicated For The Treatment Of Previously Untreated Follicular Nhl In Adult Patients Who Achieve A Partial Or Complete Response To First-Line Chemotherapy.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Ibritumomab Tiuxetan

Comments